Clinical outcomes and costs with the levonorgestrel-releasing intrauterine system or hysterectomy for treatment of menorrhagia: randomized trial 5-year follow-up.
about
Surgery versus medical therapy for heavy menstrual bleedingProgesterone or progestogen-releasing intrauterine systems for heavy menstrual bleedingLevonorgestrel-releasing intrauterine device (LNG-IUD) for symptomatic endometriosis following surgeryProgesterone or progestogen-releasing intrauterine systems for heavy menstrual bleedingSurgery versus medical therapy for heavy menstrual bleedingTrends in number of hysterectomies performed in England for menorrhagia: examination of health episode statistics, 1989 to 2002-3Review of the safety, efficacy and patient acceptability of the levonorgestrel-releasing intrauterine systemCost-effectiveness of magnetic resonance-guided focused ultrasound surgery for treatment of uterine fibroidsTherapeutic amenorrhea in patients at risk for thrombocytopenia.Hysterectomy, endometrial destruction, and levonorgestrel releasing intrauterine system (Mirena) for heavy menstrual bleeding: systematic review and meta-analysis of data from individual patients.Satisfaction and health-related quality of life in women with heavy menstrual bleeding; results from a non-interventional trial of the levonorgestrel-releasing intrauterine system or conventional medical therapy.Hysterectomy or a minimal invasive alternative? A systematic review on quality of life and satisfaction.Impact of a new levonorgestrel intrauterine system, Levosert(®), on heavy menstrual bleeding: results of a one-year randomised controlled trial.Safety, efficacy and patient acceptability of the contraceptive and non-contraceptive uses of the LNG-IUSNon-contraceptive applications of the levonorgestrel intrauterine system.Levonorgestrel-releasing intrauterine system (Mirena) in compare to medroxyprogesterone acetate as a therapy for endometrial hyperplasiaHas socioeconomic equity increased in somatic specialist care: a register-based cohort study from Finland in 1995-2010.Levonorgestrel-releasing intrauterine system: uses and controversies.Hysterectomy, endometrial ablation, and levonorgestrel releasing intrauterine system (Mirena) for treatment of heavy menstrual bleeding: cost effectiveness analysis.Cost effectiveness of endometrial ablation with the NovaSure(®) system versus other global ablation modalities and hysterectomy for treatment of abnormal uterine bleeding: US commercial and Medicaid payer perspectivesCost-effectiveness of hysterectomy for benign gynecological conditions: a systematic review.Levonorgestrel-releasing intrauterine system vs. usual medical treatment for menorrhagia: an economic evaluation alongside a randomised controlled trialAssessing responsiveness of generic and specific health related quality of life measures in heart failureLevonorgestrel intrauterine system (Mirena): An emerging tool for conservative treatment of abnormal uterine bleeding.A model-based assessment of the cost-utility of strategies to identify Lynch syndrome in early-onset colorectal cancer patients.A systematic review comparing hysterectomy with less-invasive treatments for abnormal uterine bleeding.Levonorgestrel intrauterine system versus thermal balloon ablation for the treatment of heavy menstrual bleeding: A meta-analysis of randomized controlled trials.Cost-Effectiveness of Global Endometrial Ablation vs. Hysterectomy for Treatment of Abnormal Uterine Bleeding: US Commercial and Medicaid Payer PerspectivesThe obstetric and gynaecological management of women with inherited bleeding disorders--review with guidelines produced by a taskforce of UK Haemophilia Centre Doctors' Organization.Levonorgestrel intrauterine system: Current role in management of heavy menstrual bleedingHysterectomy for Benign Uterine DiseaseClinical applications of levonorgestrel-releasing intrauterine system to gynecologic diseases.Waste in the U.S. Health care system: a conceptual framework.Abnormal uterine bleeding: a review of patient-based outcome measures.Is There Any Impact of Copper Intrauterine Device on Female Sexual Functioning?Usual medical treatments or levonorgestrel-IUS for women with heavy menstrual bleeding: long-term randomised pragmatic trial in primary care.Levonorgestrel-releasing intrauterine system--the discontinuing story.Cost-effectiveness and quality of life associated with heavy menstrual bleeding among women using the levonorgestrel-releasing intrauterine system.The levonorgestrel-releasing intrauterine system in heavy menstrual bleeding: a benefit-risk review.How I manage heavy menstrual bleeding.
P2860
Q24186320-A421F949-4C3B-47C8-9E13-B56B1BC2C789Q24186336-8FB35698-4E59-4AB0-89D3-26539B841D64Q24201678-E88C91CB-60D4-4443-A27D-A4FEF93A454CQ24245561-5E35A381-69D3-49EA-B72E-8BBC2FE482F5Q24246271-9DA58536-A296-4392-BC17-B19FC2D18DB8Q24555716-7EE6B55C-2928-4673-A834-46FF35A1F200Q24646966-49FB8C8B-DD80-4346-99C2-D0040E033F5AQ24656553-73B52217-1F17-48C6-8370-E4A660835774Q33379674-43A2C97B-00A6-417B-BFE8-CC2CCF443E73Q33659887-825A4183-A740-4FC4-ABE4-4138F829A8DAQ33706903-448AD946-4FF2-4E5C-B98B-3152287AEC51Q34040198-38C3277C-CFC5-494D-9B63-6EC22B353C69Q34049773-C3E563D6-D666-42A1-B0A2-33697F4EC081Q34272031-255DD7D1-CD3B-4E5E-BDBB-9894D23F8F6AQ34272077-1DC440A6-A185-43B4-BF99-0714E2DA7906Q34529750-979DFA52-96C3-4806-9041-6C77EFC8D2E2Q34677629-59992577-5B3B-4CD5-AC3D-687706A08163Q34788317-E2B7C848-41CD-481D-A5C1-4D050E91557DQ34857094-BAB09E41-19FE-490E-A75E-204410A2BAFCQ34960496-E2D6A193-0464-4591-AE81-0735301E83BAQ35030338-30F4245E-D9E0-424A-94AA-57A5CA551C85Q35123197-3C480D99-DA4F-46BB-BDBE-859BA61512F4Q35185453-D221BE62-2CB6-4BD8-99FC-690E866EDEA3Q35313822-FD636D73-C270-4B88-A830-73AD8D640F30Q35596050-A228C8EB-ED99-4B20-88AB-53754E193169Q35719158-C81B3624-8E9A-4B9F-A7E2-727A5A687C5FQ35861887-0F0CA277-5358-48DE-A90A-7623FB1C2172Q36362164-228C5847-CBBE-451F-B832-EA8DE5307BCEQ36533439-B4C1B478-688E-47F6-8C17-459F054BCAD6Q36984365-228C2209-EEF2-40B7-82F6-BA91D40E0FACQ37176625-58AB71D8-72F8-4BE4-9B1C-6E5CB4EAAB37Q37199883-8F6485F6-485F-4C86-B878-460E6CC7CCB2Q37212180-DB9E420C-DB81-4A45-94D8-5EC2A8933E08Q37219163-8889546F-7466-46EE-A152-AAB440FE676CQ37435647-01D80FCC-05F8-4CDE-B756-C1379DEAAC57Q37543723-A6A52117-7C28-4740-B358-0C0774C8C1C2Q37573542-8D6DAD60-2E85-4096-9D5B-0A837E38515CQ37832562-BB98ECD7-88C1-4CCB-98CD-F2501AF2A5EBQ37977978-7BFA6EBC-3064-4285-995D-7DFC3BBFD821Q38119530-1AAC86E8-B008-4FFF-B8D4-CF42F3C97A58
P2860
Clinical outcomes and costs with the levonorgestrel-releasing intrauterine system or hysterectomy for treatment of menorrhagia: randomized trial 5-year follow-up.
description
2004 nî lūn-bûn
@nan
2004 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի մարտին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Clinical outcomes and costs wi ...... omized trial 5-year follow-up.
@ast
Clinical outcomes and costs wi ...... omized trial 5-year follow-up.
@en
Clinical outcomes and costs wi ...... omized trial 5-year follow-up.
@nl
type
label
Clinical outcomes and costs wi ...... omized trial 5-year follow-up.
@ast
Clinical outcomes and costs wi ...... omized trial 5-year follow-up.
@en
Clinical outcomes and costs wi ...... omized trial 5-year follow-up.
@nl
prefLabel
Clinical outcomes and costs wi ...... omized trial 5-year follow-up.
@ast
Clinical outcomes and costs wi ...... omized trial 5-year follow-up.
@en
Clinical outcomes and costs wi ...... omized trial 5-year follow-up.
@nl
P2093
P356
P1476
Clinical outcomes and costs wi ...... omized trial 5-year follow-up.
@en
P2093
Aarre Kivelä
Anna-Mari Aalto
Erkki Kujansuu
Juha Teperi
Merja Yliskoski
Pekka Rissanen
Seija Grenman
Sirkku Vuorma
P304
P356
10.1001/JAMA.291.12.1456
P407
P577
2004-03-01T00:00:00Z